Impact of lymph node metastases on outcome following treatment with sorafenib in patients with hepatocellular carcinoma (HCC): Subset analysis from the phase III SHARP trial

被引：0
|
作者：
Raoul, J.
Craxi, A.
Porta, C.
Lentini, G.
Nadel, A.
Voliotis, D.
Bruix, J.
Llovet, J. M.
机构：
[1] Ctr Eugene Marquis, Rennes, France
[2] Azienda Osped Univ, Palermo, Italy
[3] San Matteo Univ Hosp, IRCCS, Pavia, Italy
[4] Bayer Vital GmbH, Leverkusen, Germany
[5] Bayer HealthCare Pharmaceut, Montville, NJ USA
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15547
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Sorafenib for the Treatment of Alcohol-Related Hepatocellular Carcinoma (HCC): Subanalysis of the Phase III SHARP Trial
    Trojan, J.
    Craxi, A.
    Porta, C.
    Sangiovanni, A.
    Shan, M.
    Nadel, A.
    Voliotis, D.
    Bruix, J.
    Llovet, J.
    ONKOLOGIE, 2010, 33 : 84 - 84
  • [2] SORAFENIB FOR THE TREATMENT OF ALCOHOL-RELATED HEPATOCELLULAR CARCINOMA (HCC): SUB-ANALYSIS OF THE PHASE III SHARP TRIAL
    Craxi, Antonio
    Porta, Camillo
    Sangiovanni, Angelo
    Shan, Minghua
    Nadel, Andrea
    Voliotis, Dimitris
    Bruix, Jordi
    Llovet, Josep M.
    HEPATOLOGY, 2008, 48 (04) : 971A - 971A
  • [3] Sorafenib in the treatment of advanced Hepatocellular Carcinoma (HCC) -: Experiences beyond the sharp trial
    Woerns, M.-A.
    Schulze-Bergkamen, W.
    Schuchmann, M.
    Otto, G.
    Galle, P. R.
    Weinmann, A.
    ONKOLOGIE, 2008, 31 : 80 - 80
  • [4] Phase III trial of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Cainap, Calin
    Qin, Shukui
    Huang, Wen-Tsung
    Chung, Ik-Joo
    Pan, Hongming
    Cheng, Ying
    Kudo, Masatoshi
    Kang, Yoon-Koo
    Chen, Pei-Jer
    Toh, Han Chong
    Gorbunova, Vera
    Eskens, Ferry
    Qian, Jiang
    McKee, Mark D.
    Ricker, Justin L.
    Carlson, Dawn M.
    El Nowiem, Saied
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
    Llovet, J.
    Ricci, S.
    Mazzaferro, V.
    Hilgard, P.
    Raoul, J.
    Zeuzem, S.
    Poulin-Costello, M.
    Moscovici, M.
    Voliotis, D.
    Bruix, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] BIOMARKERS PREDICTING OUTCOME OF PATIENTS WITH HEPATOCELLULAR CARCINOMA: RESULTS FROM THE RANDOMIZED PHASE III SHARP TRIAL
    Llovet, Josep
    Pena, Carol
    Shan, Minghua
    Jeffers, Michael
    Lathia, Chetan
    Bruix, Jordi
    HEPATOLOGY, 2008, 48 (04) : 372A - 372A
  • [7] Surgical treatment of lymph node metastases from hepatocellular carcinoma
    Kobayashi, Shin
    Takahashi, Shinichiro
    Kato, Yuichiro
    Gotohda, Naoto
    Nakagohri, Toshio
    Konishi, Masaru
    Kinoshita, Taira
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2011, 18 (04) : 559 - 566
  • [8] Regorafenib (REG) in patients with hepatocellular carcinoma (HCC) progressing following sorafenib: An ongoing randomized, double-blind, phase III trial
    Cheng, Ann-Lii
    Finn, Richard S.
    Kudo, Masatoshi
    Llovet, Josep M.
    Qin, Shukui
    Le Berre, Marie-Aude
    Krissel, Heiko
    Bruix, Jordi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] IMPACT OF LUNG AND LYMPH NODE METASTASIS ON EFFICACY AND SAFETY FOLLOWING TREATMENT WITH SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA FROM THE ASIA-PACIFIC REGION
    Pan, H.
    Guan, Z.
    Kang, Y. K.
    Chen, Z.
    Tsao, C. J.
    Cheng, A. L.
    Kim, J. S.
    Burock, K.
    Zou, J.
    Voliotis, D.
    Qin, S.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S295 - S295
  • [10] Phase III trial of sunitinib (Su) versus sorafenib (So) in advanced hepatocellular carcinoma (HCC)
    Cheng, A.
    Kang, Y.
    Lin, D.
    Park, J.
    Kudo, M.
    Qin, S.
    Omata, M.
    Lowenthal, S. W. Pitman
    Lanzalone, S.
    Yang, L.
    Lechuga, M.
    Raymond, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345